Nalidixic acid together with high-dose IV melphalan has caused deaths in children due to haemorrhagic enterocolitis.
Impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose IV melphalan and who subsequently received cyclosporin to prevent graft-versus-host disease.